Your browser is no longer supported. Please, upgrade your browser.
Settings
MNK Mallinckrodt plc daily Stock Chart
MNK [NYSE]
Mallinckrodt plc
Index- P/E- EPS (ttm)-41.51 Insider Own1.50% Shs Outstand83.80M Perf Week-24.70%
Market Cap212.01M Forward P/E0.33 EPS next Y7.65 Insider Trans0.67% Shs Float81.61M Perf Month-44.76%
Income-3458.00M PEG- EPS next Q1.98 Inst Own- Short Float52.34% Perf Quarter-73.06%
Sales3.25B P/S0.07 EPS this Y-421.90% Inst Trans4.62% Short Ratio5.76 Perf Half Y-89.31%
Book/sh36.70 P/B0.07 EPS next Y-9.78% ROA-29.60% Target Price5.56 Perf Year-91.47%
Cash/sh2.88 P/C0.88 EPS next 5Y-9.60% ROE-88.20% 52W Range1.43 - 32.34 Perf YTD-83.99%
Dividend- P/FCF0.29 EPS past 5Y4.35% ROI-36.70% 52W High-92.18% Beta2.52
Dividend %- Quick Ratio0.60 Sales past 5Y14.30% Gross Margin44.70% 52W Low76.92% ATR0.58
Employees3700 Current Ratio0.80 Sales Q/Q-0.30% Oper. Margin- RSI (14)38.65 Volatility15.42% 18.73%
OptionableYes Debt/Eq1.80 EPS Q/Q-115.60% Profit Margin- Rel Volume1.39 Prev Close2.53
ShortableYes LT Debt/Eq1.57 EarningsAug 06 BMO Payout- Avg Volume7.41M Price2.53
Recom3.10 SMA20-19.47% SMA50-50.38% SMA200-82.57% Volume0 Change0.00%
Sep-05-19Reiterated BofA/Merrill Underperform $5 → $1
Sep-05-19Downgrade BMO Capital Markets Outperform → Market Perform
Sep-03-19Reiterated Berenberg Sell $5 → $1
Jun-11-19Initiated Barclays Equal Weight
May-31-19Downgrade Piper Jaffray Overweight → Neutral
May-22-19Downgrade Jefferies Buy → Hold
Mar-20-19Initiated SunTrust Hold
Nov-19-18Upgrade Canaccord Genuity Hold → Buy $34 → $40
Sep-11-18Downgrade Goldman Neutral → Sell
Aug-24-18Reiterated B. Riley FBR Neutral $20 → $37
Aug-08-18Reiterated Stifel Hold $18 → $30
Aug-08-18Downgrade Raymond James Outperform → Mkt Perform
May-09-18Reiterated Barclays Underweight $20 → $12
May-02-18Initiated B. Riley FBR, Inc. Neutral $15
Mar-09-18Reiterated Mizuho Neutral $21 → $16
Feb-02-18Downgrade Barclays Equal Weight → Underweight $23 → $20
Jan-09-18Reiterated Mizuho Neutral $22 → $21
Jan-03-18Initiated Leerink Partners Mkt Perform $26
Nov-08-17Reiterated Canaccord Genuity Buy $38 → $24
Nov-08-17Downgrade Wells Fargo Outperform → Market Perform
Sep-18-19 08:55PM  SHAREHOLDER ALERT: KPTI NGHC MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE -6.64%
08:14PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Mallinckrodt Plc (NYSE: MNK) and Encourages Mallinckrodt Investors to Contact the Firm PR Newswire
11:00AM  CLASS ACTION UPDATE for MMM, NGHC and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:20AM  UPCOMING DEADLINE ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 ACCESSWIRE
Sep-17-19 03:15PM  CLASS ACTION UPDATE for MNK, NTAP and VAL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE -9.97%
01:30PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc GlobeNewswire
12:30PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MNK, SRPT and MDP ACCESSWIRE
12:15PM  Implied Volatility Surging for Mallinckrodt (MNK) Stock Options Zacks
10:30AM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc GlobeNewswire
10:02AM  CLASS ACTION UPDATE for MNK, CAH, GVA and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:25AM  7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Sep-16-19 03:14PM  OxyContin maker Purdue Pharma files for bankruptcy Yahoo Finance Video -8.79%
01:45PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of LB, MNK and ABMD ACCESSWIRE
10:55AM  INVESTOR ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 ACCESSWIRE
10:45AM  CLASS ACTION UPDATE for NFLX, MNK and ABMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:15AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm GlobeNewswire
Sep-13-19 04:30PM  SHAREHOLDER ALERT: VNTR KPTI MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE +10.37%
03:15PM  Zhang Investor Law Reminds Investors of Sept. 24 Deadline in Securities Class Action Lawsuit Against Mallinckrodt plc - MNK ACCESSWIRE
03:00PM  Class Action Update - NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC GlobeNewswire
10:50AM  SHAREHOLDER ALERT: LB MNK ABMD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:22AM  Class Action Alert - NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
06:45AM  Mallinckrodt Analysis Suggests Acthar® Gel (Repository Corticotropin Injection) May be a Cost-Effective Option Compared to Other Late-Line, Adult Treatments for Multiple Sclerosis Relapse PR Newswire
Sep-12-19 06:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPTI, EGBN and MNK ACCESSWIRE -11.01%
05:50PM  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Mallinckrodt plc Investors of Important Deadline in Securities Class Action MNK GlobeNewswire
02:30PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MMM, EGBN and MNK ACCESSWIRE
02:07PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline MNK GlobeNewswire
Sep-11-19 04:21PM  Purdue Is Inching Closer to Bankruptcy. Why Opioid Stocks Dont Care. Barrons.com -13.40%
03:12PM  Mallinckrodt's stock falls, as credit downgrade takes some shine off recent surge MarketWatch
01:16PM  A Look At Benzinga Pro's Most-Searched Tickers For September 11, 2019 Benzinga
12:13PM  Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up Zacks
11:00AM  SHAREHOLDER ALERT: NFLX NGHC MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:21AM  Class Action Update - NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
09:02AM  Mallinckrodt Stock Price Nearly Doubles, but Is Still Near Historic Lows Barrons.com
08:02AM  GameStop Stock Plunges, Mallinckrodt Soars on a Calm Morning for the Dow Barrons.com
Sep-10-19 08:05PM  CLASS ACTION UPDATE for NGHC, MNK and GTT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE +84.76%
07:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National General, Mallinckrodt, Oasmia Pharmaceutical, and Aclaris Therapeutics and Encourages Investors to Contact the Firm GlobeNewswire
03:30PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VNTR, NFLX and MNK ACCESSWIRE
02:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK ACCESSWIRE
01:41PM  Mallinckrodt to sell Canadian drug manufacturing unit for $250M American City Business Journals
12:35PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MNK, GVA and NTAP ACCESSWIRE
11:28AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm GlobeNewswire
09:30AM  Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Mallinckrodt plc - MNK ACCESSWIRE
08:12AM  Mallinckrodt to sell BioVectra business for $250 million, stock surges MarketWatch
08:09AM  UPDATE 2-Mallinckrodt sells unit for up to $250 mln, sees path forward to settle opioid lawsuits Reuters
07:58AM  Mallinckrodt To Sell BioVectra To HIG Capital For $250M Benzinga
07:08AM  [video]Mallinckrodt to Sell BioVectra Unit to H.I.G. Capital for $250 Million TheStreet.com
07:02AM  Mallinckrodt to sell unit BioVectra for up to $250 mln Reuters
06:45AM  Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million PR Newswire
Sep-09-19 05:28PM  Mallinckrodt (MNK) to Resolve Opioid Cases with Ohio Counties Zacks +12.30%
11:00AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MNK, GTT and GVA ACCESSWIRE
10:20AM  UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:20AM  Class Action Reminder - NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Sep-08-19 10:39AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of RLGY, MNK and GTT ACCESSWIRE
Sep-07-19 03:04PM  Barron's Picks And Pans: Activision, AT&T, Boeing, Ford, Nike, Square And More Benzinga
07:30AM  Bond Investors Have Finally Soured on Mallinckrodt Over Opioid Lawsuits Barrons.com
Sep-06-19 10:25PM  Zhang Investor Law Reminds Investors of Sept. 24 Deadline in Securities Class Action Lawsuit Against Mallinckrodt plc - MNK ACCESSWIRE +17.61%
08:43PM  Mallinckrodt Shares Near Penny-Stock Status as Troubles Mount Barrons.com
07:53PM  Edited Transcript of MNK earnings conference call or presentation 6-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
06:00PM  S&P Dow Jones Indices Announces Nine Companies Set to Join S&P MidCap 400; Ten Companies to Join S&P SmallCap 600 PR Newswire
05:55PM  Mallinckrodt being removed from S&P 400 as market cap shrinks MarketWatch
04:30PM  Mallinckrodt International Finance SA -- Moody's downgrades Mallinckrodt's CFR to Caa1; outlook remains negative Moody's
03:15PM  SHAREHOLDER ALERT: RLGY MNK PS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:29PM  UPDATE 1-Mallinckrodt to pay $24 mln in cash to settle opioid lawsuits with two Ohio counties Reuters
01:15PM  FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm ACCESSWIRE
12:40PM  Mallinckrodt to pay $24 mln in cash to settle opioid lawsuits with two Ohio counties Reuters
12:20PM  Mallinckrodt Announces Settlement in Principle to Resolve "Track 1" Opioid Cases with the Ohio Counties of Cuyahoga and Summit PR Newswire
12:15PM  CLASS ACTION UPDATE for RLGY, MNK and NTAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:55AM  Opioid Crisis Fallout Earns Short-Sellers an $880 Million Payday Bloomberg
11:05AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm Newsfile
09:49AM  NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC - Class Action ACCESSWIRE
09:38AM  Fears of a Mallinckrodt Bankruptcy May Be Premature Barrons.com
09:27AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of KPTI, EGBN, MNK and CAH GlobeNewswire
09:24AM  Mallinckrodt Shares Jump as Pharma Giant Settles Ohio Opioid Lawsuits TheStreet.com
08:50AM  Mallinckrodts suffers record plunge after report bankruptcy is being considered MarketWatch
08:08AM  Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation Zacks
08:00AM  Opioid Crisis Squeezes Last Air Out of a Stock Bubble Bloomberg
07:27AM  The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication Benzinga
Sep-05-19 06:00PM  ROSEN, A TOP RANKED LAW FIRM, Reminds Mallinckrodt plc Investors of Important September 24th Deadline in Securities Class Action MNK GlobeNewswire -38.61%
05:40PM  DEADLINE ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm ACCESSWIRE
04:36PM  Pharma Stock Crashes 39% On Potential Bankruptcy Amid Opioid Crisis Investor's Business Daily
03:30PM  CLASS ACTION UPDATE for INS, NFLX and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:39PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline MNK GlobeNewswire
01:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NGHC, MNK and GVA ACCESSWIRE
12:32PM  Mallinckrodt Mulls Restructuring as a Major Opioid Trial Nears Bloomberg
12:07PM  Here's Why Mallinckrodt Is Collapsing Today Motley Fool
12:00PM  Why Endo International Shares Are Tanking Today Motley Fool
10:48AM  NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC - Class Action Reminder ACCESSWIRE
10:39AM  Mallinckrodt Eyes Restructuring Ahead Of Cleveland Opioid Trial: 'Bankruptcy A Real Option' Benzinga
10:20AM  SHAREHOLDER ALERT: RBGLY MNK PS EVH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
09:51AM  Mallinckrodt Stock Is Plummeting on Report of Potential Bankruptcy Barrons.com
09:31AM  Mallinckrodt (MNK) Down 54.1% Since Last Earnings Report: Can It Rebound? Zacks
07:37AM  Mallinckrodt's stock plummets toward record low after report company is mulling bankruptcy MarketWatch
03:10AM  [video]Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy TheStreet.com
Sep-04-19 11:52PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm GlobeNewswire
06:24PM  UPDATE 1-Mallinckrodt taps restructuring firms - Bloomberg Reuters
05:42PM  Mallinckrodt taps restructuring firms - report Reuters
03:30PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LB, KPTI and MNK ACCESSWIRE
03:00PM  NFLX, KPTI & MNK - Bronstein, Gewirtz & Grossman, LLC Class Action Update GlobeNewswire
09:28AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RBGLY, NGHC, MNK and EVH GlobeNewswire
07:08AM  The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books Benzinga
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for rheumatoid arthritis, multiple sclerosis, infantile spasms, systemic lupus erythematosus, polymyositis, and others; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; and Therakos photopheresis, an immunotherapy treatment platform. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; StrataGraft, which is in Phase III and II clinical development for the treatment of burns; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105 and MNK-6106, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. It markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with the Washington University School of Medicine and Silence Therapeutics plc. The company was founded in 1867 and is based in Staines-Upon-Thames, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reasons Bryan M.EVP & CFOJun 07Buy8.965,40048,38317,979Jun 07 04:12 PM
Trudeau MarkPresident and CEOMay 30Buy9.262,00018,528233,254May 31 07:05 AM
Trudeau MarkPresident and CEOMay 09Buy16.331,00016,325231,254May 10 08:06 AM
Trudeau MarkPresident and CEOMar 05Buy22.651,00022,650229,252Mar 06 08:18 AM
Trudeau MarkPresident and CEODec 10Buy20.181,00020,180236,254Dec 11 08:30 AM